25-Desacetyl Rifampicin D3 | CAS 2734920-98-8 - Request Quote
25-Desacetyl Rifampicin D3
| SZ CAT No: | SZ-R046D05 |
| CAS No | 2734920-98-8 |
| Mol.F. | C41H53D3N4O11 |
| Mol.Wt. |
783.9 |
| Inv. Status |
Synthesis on demand |
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
25-Desacetyl Rifampicin D3 is chemically . 25-Desacetyl Rifampicin D3 is supplied with detailed characterization data compliant with regulatory guideline. 25-Desacetyl Rifampicin D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rifampicin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2734920-98-8
Purchase 2734920-98-8
Order 2734920-98-8
Enquire 2734920-98-8
price of 2734920-98-8
2734920-98-8 Supplier
2734920-98-8 Manufacturer
2734920-98-8 Exporter
buy high quality 25-Desacetyl Rifampicin D3
Purchase 25-Desacetyl Rifampicin D3
25-Desacetyl Rifampicin D3 suppliers
25-Desacetyl Rifampicin D3 manufacturers
25-Desacetyl Rifampicin D3 price
Order 25-Desacetyl Rifampicin D3
Enquire 25-Desacetyl Rifampicin D3
25-Desacetyl Rifampicin D3 cost
25-Desacetyl Rifampicin D3 Supplier
25-Desacetyl Rifampicin D3 Distributor
25-Desacetyl Rifampicin D3 for Method Validation
Rifampicin Reference Standard
25-Desacetyl Rifampicin D3 for ANDA Filing
25-Desacetyl Rifampicin D3 for Forced Degradation Studies
25-Desacetyl Rifampicin D3 Identification Standards
25-Desacetyl Rifampicin D3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.